Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)
| 0.5795 Delayed Data As of Mar 24 |  -0.0105 / -1.78%Today’s Change | 0.53 Today|||52-Week Range 3.36 | -13.12% Year-to-Date |
Latest CYCC News | Press Releases
No recent news for Cyclacel Pharmaceuticals Inc.
Today’s Trading
| Previous close | 0.59 |
| Today’s open | 0.61 |
| Day’s range | 0.58 - 0.61 |
| Volume | 15 |
| Average volume (3 months) | 99,104 |
| Market cap | $7.7M |
Data as of 3:13pm ET, 03/24/2023
Growth & Valuation
| Earnings growth (last year) | +11.09% |
| Earnings growth (this year) | +7.11% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.49 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PTIXProtagenic Therapeut... | +0.14 | +8.05% |
| AYTUAytu Biopharma Inc | +0.12 | +5.85% |
| PBLAPanbela Therapeutics... | +0.02 | +4.53% |
| VYNEVyne Therapeutics In... | 0.00 | 0.00% |
Data as of 3:59pm ET, 03/24/2023
Financials
| Next reporting date | May 16, 2023 |
| EPS forecast (this quarter) | -$0.66 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$21.2M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Berkeley Heights, New Jersey |
Forecasts
